TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/02/2023
Back to search
Official data from USPTO
MAXIM BIOMEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MAXIM BIOMEDICAL
ST13
US500000097267388Class
40
Filing
97267388
Registration
6930996
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
02/02/2023
Trademark type
Word
Nice classes
40
Filing date
02/15/2022
Registration date
12/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2022
Last transaction
12/20/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/29/2005
First use in commerce
04/29/2005
Drawing code
4
Owner type
03
Owner location
Rockville, MD
Examiner
CARLYLE, SHAUNIA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Maxim Biomedical, Inc.
Representatives
Neha Bhalani CHIESA SHAHINIAN & GIANTOMASI PC
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
custom manufacturing of in vitro medical deviceslateral flow assays and enzyme-linked immunosorbent assays
Publications
History of USPTO decisions and trademark events.
20 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/02/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2022
PUBO
PUBLISHED FOR OPPOSITION
10/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/27/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
08/18/2022
ALIE
ASSIGNED TO LIE
08/18/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/17/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
08/17/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/17/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/18/2022
GNRT
NON-FINAL ACTION E-MAILED
07/18/2022
CNRT
NON-FINAL ACTION WRITTEN
07/18/2022
DOCK
ASSIGNED TO EXAMINER
07/14/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/18/2022
NWAP
NEW APPLICATION ENTERED
02/18/2022
Continuous trademark protection
Get notified about every new filing that threatens MAXIM BIOMEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.